2026-10-25
Alto Ingredients clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,944 +1.18%
S&P 7,385 +0.42%
GOLD $4,067 −1.12%
BTC $75,586 −0.47%
VIX 25.28 −10.29%
latest tape · as of 18:01 UTC
The Screen · Basic Materials · Specialty Chemicals
Alto Ingredients Inc
ALTO · NASDAQ · USD · Market cap $278M · 390 employees
Alto Ingredients, Inc.
Not yet scored3.67 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 18:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price3.67 USD at the 5 Nov 2026 close
- Fair valueUnder review: our model's value is 1.54x the price, above our 1.35x limit.
- Our regime readMarkdown, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.03)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: range not available (screen dated 2026-11-05).
- Trend Markdown
- Insiders insiders bought, latest filing 2026-09-14
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.03, read 2026-11-05
- Ethical screen not yet scored
Price3.67 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-08-21Read Markdown4.20-12.6% to today ✓Markup gives way to Markdown after a 26% slide in 7 weeks
2026-07-02Read Markup5.70-35.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
Alto Ingredients Inc holds its Markdown at $3.67. The statistical read favours the sellers, held for 42 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 42 days |
| Price at the screen | $3.67 |
| Valuation | 5.28 trailing · 10.88 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.15 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 25.10% | Below 33% | Interest-bearing debt is just 25.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 20.19% | Below 49% | Money owed to the company is 20.2% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Alto Ingredients clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Alto Ingredients clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 25%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Our model's value is 1.54x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets. The average target sits +118% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 10.9xfairly priced for its growth rate |
| Trailing P/E | 5.3xvery cheap relative to earnings |
| EPS, trailing | 0.68 |
| EPS, forward | 0.33 |
| Revenue growth | +12.5%steady growth |
| Profit margin | 5.5%thin but positive margins |
| Return on equity | 22.2%an exceptional return on shareholder capital |
| FCF yield | 8.10% |
| Debt to equity | 0.32minimal debt: a conservative balance sheet |
| Current ratio | 3.19comfortably covers its short-term bills |
| Beta | 0.15barely tracks the market's swings |
| Short interest, float | 0.08% |
| 52-week range | 0.99 - 6.11 |
| Moat | NONE |
| Market cap | $278M |
| Employees | 390 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeALTO trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-02
Markdown $3.65
+1.7% Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9. Insiders have been net buyers over the past quarter.
2026-10-26
Markdown $3.59
-1.9% Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9. Insiders have been net buyers over the past quarter.
2026-10-19
Markdown $3.66
-1.7% Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9. Insiders have been net buyers over the past quarter.
2026-10-12
Markdown $3.72
-4.7% Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 88% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9. Insiders have been net buyers over the past quarter.
2026-10-02
Markdown $3.91
-2.7% Entry 8
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 88% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9. Insiders have been net buyers over the past quarter.
2026-09-21
Markdown $4.02
-4.3% Entry 7
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 88% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9. Insiders have been net buyers over the past quarter.
2026-08-21
Markdown · changed $4.20
-28.1% Entry 6
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 28.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 88% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9.
2026-07-21
Markup $5.84
+2.5% Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 88% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9.
2026-07-18
Markup $5.70
+0.0% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 88% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9.
2026-07-17
Markup $5.70
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 88% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 409%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $9.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Alto Ingredients, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Yahoo Finance · 14 Sep 2026
- Will Alto Ingredients' Higher Maintenance Costs Pressure Margins? Zacks · 31 Aug 2026
- Will Alto Ingredients' Higher Maintenance Costs Pressure Margins? Yahoo Finance · 31 Aug 2026
- Alto Ingredients vs. Green Plains: Which Ethanol Stock Is Better? Zacks · 26 Aug 2026
- Alto Ingredients vs. Green Plains: Which Ethanol Stock Is Better? Yahoo Finance · 26 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
GEVOGevo Inc
HDSNHudson Technologies Inc
FFFuturefuel Corp
OECOrion S.A
MNTKMontauk Renewables Inc
CMTCore Molding Technologies
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Nathan Gilbert E | Dir | P - Purchase | 10,000 | $39,299 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-21 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-21 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-21 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-21 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-14 | Kevin Hern | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4.90 | +15.2% | · | $1,152 | +15.2% |
| 2 months | $4.80 | +17.6% | · | $1,176 | +17.6% |
| 3 months | $4.75 | +18.8% | · | $1,188 | +18.8% |
| 6 months | $2.56 | +120.5% | · | $2,205 | +120.5% |
| 1 year | $1.11 | +408.6% | · | $5,086 | +408.6% |
| 2 years | $1.44 | +292.0% | · | $3,920 | +292.0% |
| 3 years | $2.40 | +135.2% | · | $2,352 | +135.2% |
| 5 years | $6.09 | -7.3% | · | $927 | -7.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ALTO does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.